Antogen, Inc.
PrivateLast Round
Seed
Jun 9, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Antogen, Inc. is a life sciences company that provides immunopeptidomics services and develops tools and diagnostics for immune surveillance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Usage-Based SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antogen, Inc. Comparables
Compare Antogen, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MS Bioworks | 77% | |
| Bruker | 74% | |
| Creative Proteomics | 74% |
Antogen, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 9, 2026 |
Antogen, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| iGrow Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 9, 2026
Seed round led by iGrow Venture Partners.
Antogen, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Antogen, Inc.'s valuation, stock price, and market status.
Is Antogen, Inc. a public or private company?
Antogen, Inc. is a private company.
What is the current stock price of Antogen, Inc.?
Antogen, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Antogen, Inc. worth (valuation)?
Valuation information for Antogen, Inc. is not publicly available.
Can I buy Antogen, Inc. stock?
Antogen, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Antogen, Inc.'s last funding round?
Antogen, Inc.'s most recent funding round was Seed on June 9, 2026.
Who are the main investors in Antogen, Inc.?
Key investors in Antogen, Inc. include iGrow Venture Partners.
Will Antogen, Inc. IPO soon?
No public IPO plans have been announced for Antogen, Inc..
How can I track Antogen, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Antogen, Inc.'s secondary market activity and sign up for updates.